These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 34826977)

  • 1. Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation.
    Mullick R; Annavajjhala S; Thakur P; Mohapatra A; Shetty R; D'Souza S
    Indian J Ophthalmol; 2021 Dec; 69(12):3473-3477. PubMed ID: 34826977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
    Ozen S; Ozer MA; Akdemir MO
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial.
    Park CH; Lee HK; Kim MK; Kim EC; Kim JY; Kim TI; Kim HK; Song JS; Yoon KC; Lee DH; Chung TY; Choi CY; Kim HS
    BMC Ophthalmol; 2019 Jun; 19(1):131. PubMed ID: 31208393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in post-refractive surgery chronic dry eye patients with ocular pain.
    Zhao L; Chen J; Duan H; Yang T; Ma B; Zhou Y; Bian L; Cai X; Qi H
    BMC Ophthalmol; 2024 Jan; 24(1):28. PubMed ID: 38247010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of efficacy and mechanism of 0.05% cyclosporine eye drops (II) monotherapy in allergic conjunctivitis-associated dry eye.
    Jiao X; Qi Y; Gao N; Zhang C; Zhao S; Yang R
    Eye (Lond); 2024 Apr; 38(5):937-944. PubMed ID: 37904000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease.
    Park JY; Kim BG; Kim JS; Hwang JH
    Transl Vis Sci Technol; 2018 Sep; 7(5):31. PubMed ID: 30386683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is gabapentin effective in dry eye disease and neuropathic ocular pain?
    Ongun N; Ongun GT
    Acta Neurol Belg; 2021 Apr; 121(2):397-401. PubMed ID: 31134508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study to assess the role of vitamin D individually and in combination with cyclosporine in the treatment of dry eye in patients with deficient serum 25(OH)D levels.
    Watts P; Sahai A; Kumar PR; Shamshad MA; Trivedi GK; Tyagi L
    Indian J Ophthalmol; 2020 Jun; 68(6):1020-1026. PubMed ID: 32461420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy evaluation of 0.05% cyclosporine A and 0.1% tacrolimus eye drops in the treatment of severe dry eye associated with chronic graft-versus-host disease].
    Liu SW; Zhao YH; Ma J; Shen Z; Hu BH; Peng RM; Hong J
    Zhonghua Yan Ke Za Zhi; 2023 Oct; 59(10):805-813. PubMed ID: 37805414
    [No Abstract]   [Full Text] [Related]  

  • 11. An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease.
    Tuan HI; Chi SC; Kang YN
    Drug Des Devel Ther; 2020; 14():265-274. PubMed ID: 32021110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome.
    Moawad P; Shamma R; Hassanein D; Ragab G; El Zawahry O
    Eur J Ophthalmol; 2022 Jan; 32(1):673-679. PubMed ID: 33530719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Enhances the Efficacy of Topical Artificial Tears in Patients With Dry Eye Disease.
    Hwang JS; Lee YP; Shin YJ
    Cornea; 2019 Mar; 38(3):304-310. PubMed ID: 30531497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application frequency - key indicator for the efficiency of severe dry eye disease treatment - evidence for the importance of molecular weight of hyaluronan in lubricating agents.
    Medic N; Boldin I; Berisha B; Matijak-Kronschachner B; Aminfar H; Schwantzer G; Müller-Lierheim WGK; van Setten GB; Horwath-Winter J
    Acta Ophthalmol; 2024 Aug; 102(5):e663-e671. PubMed ID: 38131131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
    Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
    J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
    [No Abstract]   [Full Text] [Related]  

  • 16. New Therapeutic Strategy and Innovative Lubricating Ophthalmic Solution in Minimizing Dry Eye Disease Associated with Cataract Surgery: A Randomized, Prospective Study.
    Fogagnolo P; Favuzza E; Marchina D; Cennamo M; Vignapiano R; Quisisana C; Rossetti L; Mencucci R
    Adv Ther; 2020 Apr; 37(4):1664-1674. PubMed ID: 32185729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
    Lee HS; Ji YS; Yoon KC
    Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.
    Sacchetti M; Lambiase A; Schmidl D; Schmetterer L; Ferrari M; Mantelli F; Allegretti M; Garhoefer G
    Br J Ophthalmol; 2020 Jan; 104(1):127-135. PubMed ID: 30944103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Topical Cyclosporine-A or Topical Chloroquine on Post-LASIK Ocular Surface Stability - A Randomized Controlled Trial.
    Titiyal JS; Goswami A; Kaur M; Sharma N; Maharana PK; Velpandian T; Pandey RM
    Curr Eye Res; 2023 Jun; 48(6):557-563. PubMed ID: 36800492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the preoperative use of artificial tears combined with recombinant bovine basic fibroblast growth factor on cataract patients complicated with dry eyes.
    Xiao W; Huang P
    Arq Bras Oftalmol; 2022; 87(2):0539. PubMed ID: 36169441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.